nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—submandibular gland—salivary gland cancer	0.449	0.786	CbGeAlD
Clenbuterol—NGF—saliva-secreting gland—salivary gland cancer	0.0407	0.0714	CbGeAlD
Clenbuterol—ADRB3—connective tissue—salivary gland cancer	0.0238	0.0417	CbGeAlD
Clenbuterol—TNF—lymph node—salivary gland cancer	0.0167	0.0293	CbGeAlD
Clenbuterol—NGF—lymph node—salivary gland cancer	0.0154	0.0271	CbGeAlD
Clenbuterol—ADRB1—connective tissue—salivary gland cancer	0.00975	0.0171	CbGeAlD
Clenbuterol—CYP1A1—parotid gland—salivary gland cancer	0.00714	0.0125	CbGeAlD
Clenbuterol—CYP1A1—epithelium—salivary gland cancer	0.00597	0.0105	CbGeAlD
Clenbuterol—NGF—Signalling to RAS—HRAS—salivary gland cancer	0.00302	0.00704	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—CCND1—salivary gland cancer	0.003	0.007	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—MAP2K2—salivary gland cancer	0.00291	0.00677	CbGpPWpGaD
Clenbuterol—NGF—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—salivary gland cancer	0.00289	0.00673	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—AQP1—salivary gland cancer	0.00284	0.00661	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—MAP2K2—salivary gland cancer	0.00275	0.00641	CbGpPWpGaD
Clenbuterol—ADRB1—G alpha (s) signalling events—MC3R—salivary gland cancer	0.00263	0.00613	CbGpPWpGaD
Clenbuterol—CYP1A1—lymph node—salivary gland cancer	0.00259	0.00454	CbGeAlD
Clenbuterol—ADRB2—G alpha (s) signalling events—MC3R—salivary gland cancer	0.00257	0.00599	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—FOXO3—salivary gland cancer	0.00253	0.00589	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00247	0.00575	CbGpPWpGaD
Clenbuterol—NGF—Signalling to ERKs—HRAS—salivary gland cancer	0.00246	0.00573	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—MAP2K2—salivary gland cancer	0.00243	0.00566	CbGpPWpGaD
Clenbuterol—TNF—Ceramide signaling pathway—MAP2K2—salivary gland cancer	0.00241	0.00562	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—FGFR4—salivary gland cancer	0.00234	0.00546	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CYLD—salivary gland cancer	0.00225	0.00524	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—VCAN—salivary gland cancer	0.00223	0.0052	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—DAPK1—salivary gland cancer	0.00222	0.00517	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—MAP2K2—salivary gland cancer	0.00216	0.00504	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—PIK3CA—salivary gland cancer	0.00213	0.00496	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00211	0.00492	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—MAP2K2—salivary gland cancer	0.00206	0.00481	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—PIK3CA—salivary gland cancer	0.00205	0.00477	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—HRAS—salivary gland cancer	0.00197	0.00459	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—FOXO3—salivary gland cancer	0.00194	0.00453	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—PTEN—salivary gland cancer	0.00194	0.00451	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00192	0.00446	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00189	0.00441	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—HRAS—salivary gland cancer	0.00189	0.00441	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—MAP2K2—salivary gland cancer	0.00187	0.00435	CbGpPWpGaD
Clenbuterol—NGF—p75(NTR)-mediated signaling—PIK3CA—salivary gland cancer	0.00185	0.00432	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00179	0.00418	CbGpPWpGaD
Clenbuterol—NGF—p75(NTR)-mediated signaling—TP53—salivary gland cancer	0.00179	0.00418	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—CREBBP—salivary gland cancer	0.00163	0.0038	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—MC3R—salivary gland cancer	0.00161	0.00375	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—MAP2K2—salivary gland cancer	0.00159	0.0037	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAP2K2—salivary gland cancer	0.00154	0.00359	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 trafficking events—CDH1—salivary gland cancer	0.00149	0.00348	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00146	0.00341	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00144	0.00335	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00143	0.00334	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—PIK3CA—salivary gland cancer	0.00137	0.00318	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CNTN6—salivary gland cancer	0.00136	0.00317	CbGpPWpGaD
Clenbuterol—TNF—Signaling events mediated by HDAC Class I—CREBBP—salivary gland cancer	0.00132	0.00309	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—MAP2K2—salivary gland cancer	0.00132	0.00307	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.0013	0.00304	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00127	0.00295	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00126	0.00294	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00126	0.00294	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00125	0.00292	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—CREBBP—salivary gland cancer	0.00123	0.00286	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00123	0.00286	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—WNT5B—salivary gland cancer	0.0012	0.00279	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL17RD—salivary gland cancer	0.00116	0.00269	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—PIK3CA—salivary gland cancer	0.00111	0.00259	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—EP300—salivary gland cancer	0.00111	0.00259	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.0011	0.00255	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—CREBBP—salivary gland cancer	0.00106	0.00248	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAML3—salivary gland cancer	0.00106	0.00246	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—salivary gland cancer	0.00105	0.00245	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—MAP2K2—salivary gland cancer	0.00103	0.0024	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00101	0.00236	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—MC3R—salivary gland cancer	0.000955	0.00222	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—HRAS—salivary gland cancer	0.000952	0.00222	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MC3R—salivary gland cancer	0.000942	0.0022	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—MC3R—salivary gland cancer	0.000934	0.00218	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000928	0.00216	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—MC3R—salivary gland cancer	0.000909	0.00212	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000907	0.00211	CbGpPWpGaD
Clenbuterol—TNF—Signaling events mediated by HDAC Class I—EP300—salivary gland cancer	0.000902	0.0021	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MAP2K2—salivary gland cancer	0.000885	0.00206	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TP53—salivary gland cancer	0.00088	0.00205	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—salivary gland cancer	0.000873	0.00204	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000864	0.00201	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—PTEN—salivary gland cancer	0.000842	0.00196	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—salivary gland cancer	0.000836	0.00195	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MC3R—salivary gland cancer	0.000825	0.00192	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—DTX4—salivary gland cancer	0.000824	0.00192	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000773	0.0018	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—HRAS—salivary gland cancer	0.00076	0.00177	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000715	0.00167	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000697	0.00163	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—CDH1—salivary gland cancer	0.000696	0.00162	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.000693	0.00161	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000693	0.00161	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000683	0.00159	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FGF16—salivary gland cancer	0.000681	0.00159	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—salivary gland cancer	0.000676	0.00158	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—salivary gland cancer	0.000647	0.00151	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCND1—salivary gland cancer	0.000645	0.0015	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—WNT5B—salivary gland cancer	0.000619	0.00144	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL17RD—salivary gland cancer	0.000598	0.00139	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—PIK3CA—salivary gland cancer	0.000594	0.00138	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000593	0.00138	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAML2—salivary gland cancer	0.000592	0.00138	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—salivary gland cancer	0.000586	0.00137	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—salivary gland cancer	0.000577	0.00134	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—salivary gland cancer	0.000558	0.0013	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000551	0.00128	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—HRAS—salivary gland cancer	0.00055	0.00128	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAML3—salivary gland cancer	0.000547	0.00128	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—MC3R—salivary gland cancer	0.000539	0.00126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000539	0.00126	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—MC3R—salivary gland cancer	0.000528	0.00123	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—CREBBP—salivary gland cancer	0.000506	0.00118	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JAG1—salivary gland cancer	0.000505	0.00118	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FGFR4—salivary gland cancer	0.000503	0.00117	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—HRAS—salivary gland cancer	0.000496	0.00116	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.000495	0.00115	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FBXW7—salivary gland cancer	0.000495	0.00115	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—salivary gland cancer	0.000494	0.00115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MC3R—salivary gland cancer	0.00049	0.00114	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MC3R—salivary gland cancer	0.000488	0.00114	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MC3R—salivary gland cancer	0.000479	0.00112	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000475	0.00111	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000474	0.0011	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000469	0.00109	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—FOXO3—salivary gland cancer	0.000457	0.00107	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000442	0.00103	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.000442	0.00103	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000439	0.00102	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DTX4—salivary gland cancer	0.000426	0.000993	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—salivary gland cancer	0.000425	0.000991	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000424	0.000987	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FOXO3—salivary gland cancer	0.000418	0.000973	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000404	0.000942	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	0.000385	0.000898	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MAP2K2—salivary gland cancer	0.000373	0.00087	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—WNT5B—salivary gland cancer	0.000368	0.000857	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ISYNA1—salivary gland cancer	0.000365	0.00085	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—WNT5B—salivary gland cancer	0.00036	0.000838	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL17RD—salivary gland cancer	0.000355	0.000827	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGF16—salivary gland cancer	0.000353	0.000822	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL17RD—salivary gland cancer	0.000347	0.000809	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—EP300—salivary gland cancer	0.000345	0.000804	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—salivary gland cancer	0.000342	0.000796	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.000341	0.000796	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAP2K2—salivary gland cancer	0.000341	0.000795	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.000337	0.000787	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAML3—salivary gland cancer	0.000325	0.000757	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—salivary gland cancer	0.00032	0.000747	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAML3—salivary gland cancer	0.000318	0.00074	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAML2—salivary gland cancer	0.000306	0.000714	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NOTCH1—salivary gland cancer	0.000306	0.000713	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000302	0.000704	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000299	0.000697	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000299	0.000696	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MARCKS—salivary gland cancer	0.000297	0.000693	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MC3R—salivary gland cancer	0.000289	0.000675	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000289	0.000674	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MC3R—salivary gland cancer	0.000283	0.00066	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NOTCH1—salivary gland cancer	0.000279	0.000651	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000279	0.000649	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CREBBP—salivary gland cancer	0.000277	0.000646	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PYGB—salivary gland cancer	0.000276	0.000644	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000273	0.000635	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JAG1—salivary gland cancer	0.000261	0.000609	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGFR4—salivary gland cancer	0.00026	0.000607	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FBXW7—salivary gland cancer	0.000256	0.000597	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CREBBP—salivary gland cancer	0.000253	0.00059	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DTX4—salivary gland cancer	0.000253	0.00059	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DTX4—salivary gland cancer	0.000247	0.000577	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.000233	0.000542	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000232	0.000542	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PHGDH—salivary gland cancer	0.000225	0.000525	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ST3GAL4—salivary gland cancer	0.000217	0.000505	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FOXO3—salivary gland cancer	0.000216	0.000504	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF16—salivary gland cancer	0.000209	0.000488	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF16—salivary gland cancer	0.000205	0.000477	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AQP1—salivary gland cancer	0.000197	0.000459	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.00019	0.000442	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EP300—salivary gland cancer	0.000189	0.00044	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCND1—salivary gland cancer	0.000187	0.000437	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAML2—salivary gland cancer	0.000182	0.000424	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PTEN—salivary gland cancer	0.000181	0.000422	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAML2—salivary gland cancer	0.000178	0.000414	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000177	0.000413	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000176	0.000411	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000176	0.000411	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000173	0.000404	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EP300—salivary gland cancer	0.000173	0.000402	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NUP62—salivary gland cancer	0.000156	0.000364	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAG1—salivary gland cancer	0.000155	0.000362	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—VCAN—salivary gland cancer	0.000155	0.000361	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGFR4—salivary gland cancer	0.000155	0.00036	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FBXW7—salivary gland cancer	0.000152	0.000354	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAG1—salivary gland cancer	0.000152	0.000354	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGFR4—salivary gland cancer	0.000151	0.000352	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FBXW7—salivary gland cancer	0.000149	0.000347	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000145	0.000337	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000144	0.000335	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000138	0.000322	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000136	0.000317	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CREBBP—salivary gland cancer	0.000131	0.000305	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—salivary gland cancer	0.000129	0.000301	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FOXO3—salivary gland cancer	0.000128	0.000299	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PIK3CA—salivary gland cancer	0.000128	0.000297	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000126	0.000293	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FOXO3—salivary gland cancer	0.000125	0.000292	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—salivary gland cancer	0.000123	0.000288	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000123	0.000287	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—salivary gland cancer	0.000118	0.000275	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000112	0.000261	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000105	0.000244	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—salivary gland cancer	0.000103	0.000241	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000102	0.000239	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NUP62—salivary gland cancer	9.96e-05	0.000232	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—VCAN—salivary gland cancer	9.88e-05	0.00023	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.71e-05	0.000226	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—salivary gland cancer	9.7e-05	0.000226	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—salivary gland cancer	9.36e-05	0.000218	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	9.26e-05	0.000216	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—salivary gland cancer	8.93e-05	0.000208	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	8.67e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH1—salivary gland cancer	8.58e-05	0.0002	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH1—salivary gland cancer	8.39e-05	0.000196	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CREBBP—salivary gland cancer	7.78e-05	0.000181	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CREBBP—salivary gland cancer	7.61e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.31e-05	0.00017	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.15e-05	0.000167	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.85e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CA—salivary gland cancer	6.63e-05	0.000155	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CA—salivary gland cancer	6.6e-05	0.000154	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CA—salivary gland cancer	6.49e-05	0.000151	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—salivary gland cancer	6.39e-05	0.000149	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	6.19e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—salivary gland cancer	6.14e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—salivary gland cancer	6.11e-05	0.000142	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CREBBP—salivary gland cancer	6.05e-05	0.000141	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—salivary gland cancer	6e-05	0.00014	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.9e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—salivary gland cancer	5.76e-05	0.000134	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—salivary gland cancer	5.63e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—salivary gland cancer	5.56e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—salivary gland cancer	5.43e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—salivary gland cancer	5.3e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—salivary gland cancer	5.18e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.37e-05	0.000102	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—salivary gland cancer	4.32e-05	0.000101	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—salivary gland cancer	4.12e-05	9.61e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CA—salivary gland cancer	3.92e-05	9.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CREBBP—salivary gland cancer	3.86e-05	9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CA—salivary gland cancer	3.83e-05	8.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—salivary gland cancer	3.79e-05	8.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—salivary gland cancer	3.71e-05	8.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—salivary gland cancer	3.63e-05	8.45e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—salivary gland cancer	3.55e-05	8.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CA—salivary gland cancer	3.05e-05	7.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—salivary gland cancer	2.76e-05	6.43e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—salivary gland cancer	2.63e-05	6.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	1.94e-05	4.53e-05	CbGpPWpGaD
